Improving The Quality Of Consent To Randomised Controlled Trials Using Continuous Consent And Clinician Training In The
Consent Process ABSTRACT Objectives: To assess whether continuous consent, a process whereby information is given to research participants at different stages in a trial, plus clinician training in that process was effective when used by clinicians gaining consent to the TOBY trial. The TOBY trial is a randomised controlled trial investigating the use of whole body cooling for neonates with evidence of perinatal asphyxia.
Obtaining valid informed consent for TOBY is difficult; as such, it is a good test of the effectiveness of continuous consent.
Methods: Semi-structured interviews were conducted with 30 sets of parents who gave consent to TOBY and with 10 clinicians who sought it using the continuous consent process. Analysis focused on the validity of parental consent based upon the consent components of competence, information, understanding and voluntariness.
Results: 19/27 (70%) couples had no significant problems with consent validity at the point of signature. Problems lay mainly with the parents' competence and understanding. Mothers particularly had competence problems in the early stages of consent.
The understanding problems were primarily to do with side effects.
markedly, particularly for mothers, in the post signature phase when further discussion took place. Randomisation was generally understood but unpopular. Clinicians did not always give information in stages during the short period of time available before parents gave consent. However, most clinicians were able to give follow up information.
Discussion: The consent validity compares favourably with similar trials examined in a comparable study (the Euricon study).
Conclusion:
Researchers should consider adopting elements of the continuous consent process and clinician training in RCTs, particularly where they have concerns about the quality of consent they are likely to obtain using a conventional process.
INTRODUCTION
The TOBY-QUAL study aimed to evaluate the process of continuous consent used during the MRC funded TOBY trial. TOBY is a randomised controlled trial (i.e. a research study in which patients are allocated at random to receive one of two or more clinical interventions) in which babies born with evidence of perinatal asphyxia are randomised either to receive conventional care or conventional care plus whole body cooling (to 34 o C) on a special mattress for 72 hours. It presents a challenge for clinicians to obtain valid, informed consent from parents of neonates for at least three reasons: first, the trial involves very sick infants; second, the trial treatment needs to be started within six hours of birth; and third, treatment is not blind, even to the parents, and yet babies in the control group born away from specialist treatment centres will need to be transferred to one of these centres. The stress for parents is compounded by the fact that perinatal asphyxial encephalopathy is almost always unexpected. Such circumstances threaten the validity of consent (1, 2).
The continuous consent approach to obtaining informed consent for RCTs has been proposed as a method for ameliorating this difficulty (3) . It involves giving parents information at more than one point in the trial in the hope that they will assimilate it better. Such an approach is used in the TOBY trial. It has three main elements (4): In addition, clinicians are given training in obtaining informed consent
for TOBY and at all times, a senior investigator is available to discuss concerns raised by parents during the trial. As the trial took place during the critical opening 72 hours of the neonate's life, the availability of a senior investigator (who was also a senior clinician involved in the baby's care) was fairly reliable although there may have been some delay at times (e.g. in the middle of the night).
Continuous consent aims to obtain the best possible informed consent in a situation of urgency. However, it has not been evaluated. The objective of 'TOBY-QUAL', the qualitative sub-study reported here, was to evaluate the process of continuous consent used in TOBY. A score was given for each parent both for the point at which they gave formal signed consent and for the point at which they had further discussion with the clinician after the signature but during the treatment phase. These scores were then assimilated and an overall score was given first, for each parent and then for the couple as a whole. The interviews were also analysed with a view to discerning common themes.
METHODS
Determining in which category to place the components involved judging the interviews against the criteria for informed consent that has developed across a wide range of ethical and legal literature. For example, the Re. C UK legal judgement gives several criteria by which to judge competence (7) . Thus, were a mother to have received opiates to the extent that she were no longer able fully to retain the necessary information to give informed consent then this would be deemed either a significant or a serious problem (depending on how impaired she was). In a similar way, we would judge parents to have a problem with understanding if, for example, they were unable to give a description of how treatment was randomly assigned. To ensure reliability of analysis, the two investigators analysed each interview independently.
RESULTS

Background data
Between January 2003 and July 2004, there were 55 eligible TOBY-QUAL babies. Five sets of parents were excluded: one because of poor English, the rest because the consultant asked us not to approach the parents. In all these cases the baby had died and the consultant felt it inappropriate to approach the parents, for example, because he or she thought it would be unduly upsetting to talk about the study.
The remaining 50 were asked to take part in TOBY-QUAL. 20 refused or did not respond to the request; 30 were interviewed. Of the parents interviewed, the split between those whose babies received the trial treatment and control was 17/13. 4/30 (13%) interviews were with the mother alone, the rest with both parents. In all but one case, both parents were available to give consent to TOBY. Ten clinicians were interviewed. Demographic information is provided in table I.
Use of the continuous consent process
Many parents did not recall the process being used precisely as set out above (Table II) . The first information sheet is envisioned mainly for use when babies are to be transferred from an outlying hospital; as such, its absence was not considered a deviation from the continuous consent process if it was not given in cooling centres. We deemed more significant any deviations from elements 2 or 3. Overall, the process was followed fully in 17 cases, mostly in seven, but was not followed in six cases.
Validity of consent
At the point of signature, the overall consent validity for the couple, taking the best score of either parent was as follows: 19/27 (70%) had a validity score of 1 or 2 (i.e. perfect or with minor problems); 8/27
(30%) had a validity score of 3 or 4 (i.e. significant or serious problems). For three sets of parents there were missing data for the father (e.g. where the mother was interviewed alone).
A key finding was the improvement in consent validity at signature to that post signature for each parent (Table III) 
Attitudes to the consent process
26/27 (96%) sets of parents said they felt it was right that clinicians sought their consent for the trial (missing data from three sets of parents). Some parents talked of their right to decide on behalf of their child. Other parents said that being asked for consent enabled them to feel involved in their child's care, perhaps for the first time.
Clinicians also generally viewed consent as valuable or necessary.
However, at least two pointed to the scientific cost involved in delaying randomisation and trial entry whilst obtaining consent.
Only two parents noted problems with the use of continuous consent itself. Both related to receiving additional information at a later stage. 
DISCUSSION
Interpretation of the study requires discussion of its limitations. First, we relied on the memory of participants, which may be flawed (8) .
This problem applies to any interview-based study of a phenomenon.
It is obviated in our study by the fact that 12/30 (40%) interviews were conducted within one month of the baby's birth, and 22/30 (73%) within three months; all were conducted within 12 months. Second, parents were willing to criticise elements of the consent process, particularly randomisation. Third, it would be odd for there to be a Hawthorne effect in the TOBY-QUAL study that was not present in the many other studies of consent to RCTs that found poorer quality consent.
Another limitation relates to our sample. Twenty sets of parents either declined or did not respond to our interview request. There were a higher proportion of deaths in the non-respondent group (40% against 13%). However, one should bear in mind that many of the babies that survived were impaired to varying degrees. Their parents would not necessarily have a particularly rosy view of the TOBY trial compared with those whose babies died. Another issue is that we interviewed only parents who gave consent to TOBY. There were some parents who refused it. Our reason for excluding this group is that they did not go through the continuous consent process and, therefore, could not comment on it.
TOBY-QUAL's chief aim was to judge whether or not the standardised, continuous consent process used in the TOBY trial was successful at getting valid informed consent from parents. The time available for consent is short and the research is looking at a treatment for a life threatening condition in the neonate. The Euricon study (1) interviewed 30 sets of parents who had given consent to similar studies. In the Euricon study, at the point of signature, there were such an approach could be more helpful than a generic one.
A second aspect is treating informed consent as a process rather than a point (i.e. the point where a signature is given). This recommendation has been made before (13) . In TOBY it is done through graded information (element 1, followed by element 2) prior to signed consent and formal follow-up discussion (element 3). We found element 3 to be most helpful to mothers who are unwell after the birth. As such it might be of particular use where consent is obtained from people with acute illnesses. However, many of the fathers also seemed to benefit from the follow-up; hence its use should not necessarily be restricted to the acutely ill. 
Element 2
If eligible, parents given second, longer information sheet and the trial is discussed with them. They are then asked for written consent. This must be given within six hours of birth if the baby is to be admitted to the trial.
Element 3
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